Starling Oncology, Inc. Payments to Acquire Marketable Securities
Starling Oncology, Inc. (STLN) reported Payments to Acquire Marketable Securities of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-26.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2025-03-26
- Starling Oncology, Inc. payments to acquire marketable securities for the quarter ending 2024-12-31 was $0.00.
- Starling Oncology, Inc. payments to acquire marketable securities for the quarter ending 2024-09-30 was $0.00.
- Starling Oncology, Inc. payments to acquire marketable securities for the quarter ending 2024-06-30 was $0.00.
- Starling Oncology, Inc. payments to acquire marketable securities for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- Starling Oncology, Inc. payments to acquire marketable securities for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Starling Oncology, Inc. payments to acquire marketable securities for fiscal 2023 was $9.60M, a 91.83% decline from fiscal 2022.
- Starling Oncology, Inc. payments to acquire marketable securities for fiscal 2022 was $117.51M.
- Starling Oncology, Inc. payments to acquire marketable securities for fiscal 2021 was $0.00.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $0.00 derived: sum of 2 quarters · filed 2025-03-26 | $0.00 derived: sum of 3 quarters · filed 2025-03-26 | $0.00 10-K · filed 2025-03-26 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $0.00 derived: sum of 2 quarters · filed 2024-11-13 | $0.00 10-Q · filed 2024-11-13 | -$88.00K derived: sum of 4 quarters · filed 2025-03-26 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $0.00 10-Q · filed 2024-08-13 | -$88.00K derived: sum of 3 quarters · filed 2025-03-26 | -$152.00K derived: sum of 4 quarters · filed 2025-03-26 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-14 | -$88.00K derived: sum of 2 quarters · filed 2025-03-26 | -$152.00K derived: sum of 3 quarters · filed 2025-03-26 | -$164.00K derived: sum of 4 quarters · filed 2025-03-26 |
| 2023-12-31 | -$88.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | -$152.00K derived: sum of 2 quarters · filed 2025-03-26 | -$164.00K derived: sum of 3 quarters · filed 2025-03-26 | $9.60M 10-K · filed 2025-03-26 |
| 2023-09-30 | -$64.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$76.00K derived: sum of 2 quarters · filed 2024-11-13 | $9.68M 10-Q · filed 2024-11-13 | $39.79M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | -$12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $9.75M 10-Q · filed 2024-08-13 | $39.85M derived: sum of 3 quarters · filed 2024-08-13 | $127.25M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $9.76M 10-Q · filed 2024-05-14 | $39.87M derived: sum of 2 quarters · filed 2024-05-14 | $127.27M derived: sum of 3 quarters · filed 2024-05-14 | $127.27M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $30.11M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $117.51M derived: sum of 2 quarters · filed 2024-03-28 | $117.51M derived: sum of 3 quarters · filed 2024-03-28 | $117.51M 10-K · filed 2024-03-28 |
| 2022-09-30 | $87.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $87.40M derived: sum of 2 quarters · filed 2023-11-08 | $87.40M 10-Q · filed 2023-11-08 | $87.40M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $0.00 10-Q · filed 2023-08-09 | $0.00 derived: sum of 3 quarters · filed 2023-08-09 | |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-10 | $0.00 derived: sum of 2 quarters · filed 2023-05-10 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $0.00 10-K · filed 2023-03-16 | ||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-09 |